Prostate Cancer Clinical Trials in San Francisco

Showing 261-261 of 261 trials

Study of DN-101 (Calcitriol) and Docetaxel in Subjects Previously Enrolled in Studies DN101-002 or DN101-004

NCT00285675

The purpose of this study is to monitor the safety of continued DN-101 and docetaxel treatment for subjects previously enrolled in DN101-002 (ASCENT) or DN101-004 (NSCLC) Studies.

Androgen Independent Prostate Cancer (AIPC)Non Small Cell Lung Cancer (NSCLC)

Novacea25 participantsStarted Apr 2006

Berkeley, California, United States • San Francisco, California, United States • Vallejo, California, United States +10 more locations

Study of DN-101 (Calcitriol) and Docetaxel in Subjects Previously Enrolled in Studies DN101-002 or DN101-004

Prostate Cancer Trials in Other Cities

Other Conditions in San Francisco